ArticleScience advances2026
Deoxygenative functionalization of alcohols, ethers, and carbonyl compounds by chromium catalysis.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of an efficient and unified methodology for converting ubiquitous alcohols, ethers, carbonyls, and esters into value-added products via the activation of C-O single and double bonds is of great interest and importance but remains a challenging goal. Herein, we report an efficient and general chromium-catalyzed strategy for the deoxygenative functionalization of alcohols, ethers, and carbonyl compounds with a number of electrophiles. This general strategy couples these oxygenated functional groups with a number of electrophiles, providing an efficient route for the synthesis of a broad range of synthetically appealing organosilicon, organogermanium, organostannane, and organoboron compounds. Moreover, this chromium-catalyzed strategy is demonstrated to be readily scalable and applicable to the late-stage functionalization of various biorelevant molecules. Mechanistic investigations suggest that this deoxygenative functionalization was initiated by two-electron oxidative addition of the C-O bond to a highly active, low-valent chromium species, generating an organochromium intermediate that reacts with a number of electrophiles to construct C-Si, C-Ge, C-Sn, and C-B bonds.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.